Inhaled Corticosteroids Associated With 34% Increase in Diabetes Onset
Inhaled corticosteroids are commonly made use of for treating asthma and COPD (chronic obstructive pulmonary disease).
These medications may however be related to the development and progression of diabetes.
Researchers have discovered that inhaled corticosteroids were linked to a 34% increase in the rate of onset and progression of diabetes.
On the highest doses inhaled, the risk increased by 64 percent in onset of diabetes, and 54 percent in the progression of diabetes. Even though inhaled corticosteroids are advised only for individuals with the most severe COPD, recent practice has resulted in them being used in less severe cases.
The fact is, more than 70% of all individuals having COPD are making use of inhaled corticosteroids. Considering that COPD and diabetes have a tendency to increase with age, it’s especially important to determine any possible interaction between the use of inhaled corticosteroids and glycemic control deterioration.
Image via: Inhaled Corticosteroids Associated With 34% Increase in Diabetes Onset
Read full article at Health Blog